Biotalys Reports Full-Year 2025 Financial Results and Business HighlightsUnusual Whales·Apr 29 at 12:01 AMBTAI-2.42%TBIO0.00%
Terremoto wins $108m in Series C to drive cancer and rare disease programmesPharmaceutical Technology·Apr 16 at 04:39 AMTBIO0.00%MBX+3.36%
Telesia Extends Timetable for 2025 Accounts and Updates 2026 Financial CalendarTip Ranks·Mar 17 at 09:52 AMLABU+8.82%IBB+1.82%
Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026Tip Ranks·Mar 10 at 06:28 AMXBI+3.00%ASMB+0.14%
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular DystrophyTip Ranks·Feb 18 at 01:27 PMTBIO0.00%XBI+3.00%
GeminiBio partners with Tolemy Bio to launch aiMOS™, the first AI-enabled media optimization service for cell therapy.Unusual Whales·Feb 10 at 06:45 AMFBT+1.27%ARKG+4.27%
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States | MSLE Stock NewsStockTitan·Feb 5 at 11:30 PMPBE+1.47%FBT+1.27%
23:36 ET Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agentprnewswire·Jan 31 at 10:38 PMCS精准医+2.24%588250+1.15%
